Issue 9/2009
Content (8 Articles)
The Role of Patient Preferences in Cost-Effectiveness Analysis
John E. Brazier, Simon Dixon, Julie Ratcliffe
Methods for Measuring Temporary Health States for Cost-Utility Analyses
Davene R. Wright, Eve Wittenberg, J. Shannon Swan, Rebecca A. Miksad, Lisa A. Prosser
Head Lice Treatments and School Policies in the US in an Era of Emerging Resistance
Itzhak Gur, Ronald Schneeweiss
A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
Sandra L. Tunis
Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
Petra Menn, Rolf Holle
The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching
Daniel Polsky, Daria Eremina, Gregory Hess, Jerrold Hill, Scott Hulnick, Adam Roumm, Joanna L. Whyte, Joel Kallich
Utilities of the EQ-5D
Saskia Knies, Silvia M. A. A. Evers, Math J. J. M. Candel, Johan L. Severens, André J. H. A. Ament
Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
Ronald R. White, Greg Lenhart, Puneet K. Singhal, Ralph P. Insinga, Robbin F. Itzler, James M. Pellissier, Athur W. Segraves